EC-104 Intravitreal Implant for the Treatment of Diabetic Macular Edema
Clinical trial NCT06536491 · RECRUITING
Trial details
- NCT number
- NCT06536491
- Sponsor
- Eclipse Life Sciences, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-19
- Primary completion
- 2025-12-31
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.